As I connected with colleagues to understand the pulse of Greater Philadelphia’s life sciences market, I found three trends that may positively impact the sector. Check out my article in the Philadelphia Business Journal to learn more. #lifesciences #deloitte #philadelphia Brian Corvino Gerald Miceli Nick Anselmo Daniel Ressler John Conrad
Sandy Pfeffer’s Post
More Relevant Posts
-
Austin's Life Sciences industry is on the rise, quickly climbing the national ranks with the support of public and private investment. A recent market study from McKinsey & Company presented at Opportunity Austin's Life Sciences meeting last week highlighted our sectors quick expansion. ABJ wrote a good article summarizing that study, link below. Developers have bought-in and are focused on providing lab and manufacturing ready spaces to accommodate the increasing demand, making our local landscape even more attractive and agile. For those navigating these complex projects in the Austin market, or exploring other technical opportunities in Texas, we can help lead you on that journey. Stay tuned for more exciting updates on the flourishing Life Sciences sector in Austin and beyond! Project Management Advisors, Inc. #Austin #Texas #LifeSciences #OpportunityAustin
Austin's life sciences sector is booming — can it catch up to other top U.S. hubs? - Austin Business Journal
bizjournals.com
To view or add a comment, sign in
-
What’s the key to rapid growth in life sciences? Whether you’re an investor, startup, or executive at a big pharma company, you’ve probably wondered: 𝐇𝐨𝐰 𝐜𝐚𝐧 𝐈 𝐬𝐜𝐚𝐥𝐞 𝐟𝐚𝐬𝐭𝐞𝐫, 𝐜𝐮𝐭 𝐭𝐡𝐫𝐨𝐮𝐠𝐡 𝐫𝐞𝐝 𝐭𝐚𝐩𝐞, 𝐚𝐧𝐝 𝐚𝐜𝐜𝐞𝐬𝐬 𝐭𝐡𝐞 𝐛𝐞𝐬𝐭 𝐭𝐚𝐥𝐞𝐧𝐭 𝐚𝐧𝐝 𝐫𝐞𝐬𝐨𝐮𝐫𝐜𝐞𝐬? Here’s a hint: In the US it’s not just Boston or San Francisco anymore. In an episode recorded after Bio International 2022 in San Diego, I had the pleasure of speaking with E Jane Caraway, Director of Life Sciences at the Georgia Department of Economic Development. Together, we explored a surprising insight that might just change your perspective on where the next major life sciences hub is emerging. Let’s face it – scaling a life sciences company is hard, especially when you’re battling high costs, talent shortages, and navigating regulations. Whether you’re in deep tech, biotech, or pharma, you know the struggle. But what if I told you there’s a place that solves these problems without compromising innovation? Jane shares how Georgia has quietly become a global life sciences powerhouse, with a collaborative ecosystem that’s helping companies like Boehringer Ingelheim, Boston Scientific, and startups like Pain Care Labs - Vibration Neuromodulation grow exponentially. Want to know how they’re doing it? Here are 3 key steps they’ve mastered: 𝐏𝐮𝐛𝐥𝐢𝐜-𝐏𝐫𝐢𝐯𝐚𝐭𝐞 𝐂𝐨𝐥𝐥𝐚𝐛𝐨𝐫𝐚𝐭𝐢𝐨𝐧 Georgia’s secret? Government that’s easy to work with. As E Jane puts it: "𝘞𝘦 𝘸𝘢𝘯𝘵 𝘱𝘦𝘰𝘱𝘭𝘦 𝘵𝘰 𝘴𝘶𝘤𝘤𝘦𝘦𝘥, 𝘢𝘯𝘥 𝘸𝘦 𝘸𝘢𝘯𝘵 𝘵𝘰 𝘣𝘦 𝘢 𝘱𝘢𝘳𝘵𝘯𝘦𝘳 𝘢𝘯𝘥 𝘨𝘦𝘵 𝘰𝘶𝘵 𝘰𝘧 𝘺𝘰𝘶𝘳 𝘸𝘢𝘺. 𝘞𝘦 𝘤𝘰𝘯𝘵𝘪𝘯𝘶𝘢𝘭𝘭𝘺 𝘳𝘢𝘯𝘬 𝘯𝘶𝘮𝘣𝘦𝘳 𝘰𝘯𝘦 𝘧𝘰𝘳 𝘵𝘩𝘦 𝘦𝘢𝘴𝘪𝘦𝘴𝘵 𝘴𝘵𝘢𝘵𝘦 𝘵𝘰 𝘥𝘰 𝘣𝘶𝘴𝘪𝘯𝘦𝘴𝘴 𝘸𝘪𝘵𝘩. 𝘖𝘶𝘳 𝘤𝘰𝘴𝘵 𝘰𝘧 𝘣𝘶𝘴𝘪𝘯𝘦𝘴𝘴 𝘪𝘴 𝘭𝘰𝘸, 𝘢𝘯𝘥 𝘸𝘦’𝘭𝘭 𝘩𝘦𝘭𝘱 𝘺𝘰𝘶 𝘨𝘦𝘵 𝘵𝘩𝘦𝘳𝘦." 𝐓𝐚𝐥𝐞𝐧𝐭 𝐏𝐢𝐩𝐞𝐥𝐢𝐧𝐞 𝐟𝐫𝐨𝐦 𝐔𝐧𝐢𝐯𝐞𝐫𝐬𝐢𝐭𝐢𝐞𝐬 With 300,000 graduates a year from Georgia’s universities, they’re tackling the talent gap by training the workforce to fit the exact needs of life sciences companies. And they’re starting early — down to sixth grade, teaching real-life biotech skills. 𝐋𝐨𝐠𝐢𝐬𝐭𝐢𝐜𝐬 𝐟𝐨𝐫 𝐆𝐥𝐨𝐛𝐚𝐥 𝐒𝐜𝐚𝐥𝐞 Located within a two-hour flight from 80% of the U.S. population, Georgia’s infrastructure means your life-saving products get where they need to be — fast. Curious yet? We also dove into real stories — from startups like Pain Care Labs (featured on Shark Tank!) to major players like Boehringer Ingelheim, showing just how vibrant and supportive Georgia’s life sciences community has become. Want to hear how Georgia is quietly stealing the spotlight from traditional biotech hubs? Listen to the full episode here [https://lnkd.in/d_-TQJBP]. Oh, and don’t miss Bio Europe in Stockholm to explore Europe's top life science hubs and forge valuable connections! #LifeSciences #Biotech #BioEurope #DeepTech #Pharma #StartupScaling
To view or add a comment, sign in
-
🔬Is Austin FINALLY on the cusp of a life sciences boom? Opportunity Austin commissioned a report by McKinsey & Company that suggests it is. The life sciences sector in Austin has seen remarkable growth, with a 137% increase in venture capital investment between 2018 to 2023. Today, the metro is home to more than 300 life sciences companies and 1,000 startups, employing 21,000 people. Over $1bn has been spent on research funding, with 1.5 million square feet of life sciences facilities under construction. And MD Anderson Cancer Center is on the way to town. Despite this, Austin is still rarely mentioned alongside the country's top life science hubs. But as the sector keeps maturing and growing, could we see Austin named among the nation's key centers for life sciences research, development, and investment? Austin friends, what say you? #LifeSciences #Austin #Investment #Growth #medtech
To view or add a comment, sign in
-
Exciting News from Austin’s Life Sciences Sector! 🚀 We’re thrilled to share some highlights from a recent presentation that showcases Austin’s burgeoning life sciences ecosystem. Here’s why Austin is rapidly becoming a hub for innovation and growth in this dynamic field: Rapid Growth: Austin’s GDP is soaring, thanks to a 30% population increase since 2010, making it the fastest-growing MSA. Talent Hub: With nearly 300 life sciences companies and over 21,000 employees, Austin is a magnet for talent, especially with UT Austin’s top-tier research and education. Strategic Vision: Stakeholders are united in transforming Austin into a life sciences nexus, leveraging its tech foundation and quality of life to attract businesses and talent. Innovation Leader: Ranking #6 in VC funding per capita in the US, Austin’s robust R&D infrastructure and tech expertise are driving life sciences forward. Cultural Capital: Events like SXSW and specialized incentives are nurturing a culture of innovation, further cementing Austin’s position as a leader in MedTech and digital health. Austin’s life sciences landscape is poised for unprecedented advancements. Join us in celebrating this journey towards becoming a key player in the industry. Let’s innovate together! #LifeSciences #Innovation #Austin #Growth #MedTech #DigitalHealth #Talent #Research #VC #SXSW
Austin’s Innovation Ecosystem Provides Competitive Edge in Life Sciences
https://opportunityaustin.com
To view or add a comment, sign in
-
Moving scientific discoveries to patients requires the expertise and support of many groups. At “Innovating for Cures,” a recent event held at The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology, innovators, philanthropists and venture capital investors shared their thoughts on accelerating biomedical research advances to people with significant unmet medical needs. Benjamin Patz, managing partner of DeepWork Capital, manager of the #FloridaOpportunityFund, shared some encouraging statistics: 38,000 tech companies and more than 120 billion-dollar companies are based in #florida . Florida ranks fourth in the United States for total #technologyjobs , with over 440,000. Florida was also No. 1 in the nation in both 2021 and 2022 for new technology businesses established. Today, Florida universities invest more than $1.4 billion annually in life-science R&D, he noted. “We believe there’s an opportunity to invest here in Florida,” Patz said. The event was jointly sponsored by The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology; UF Innovate | Accelerate, the University of Florida’s technology licensing arm; and DeepWork Capital, a venture capital group that manages the Florida Opportunity Fund. FloridaCommerce Read more about the event: https://lnkd.in/grQgBzf3 Would you like to be on the mailing list for future events? Sign up for our newsletter: https://lnkd.in/gwV-5WwC
To view or add a comment, sign in
-
The Life Science industry is poised for massive global growth, which *𝙘𝙤𝙪𝙡𝙙* benefit the Toronto region by attracting more foreign-owned companies and improving the retention of home-grown companies looking to scale. While we have many of the required resources to make this a world-class destination for the world's leading life sciences businesses: an incredibly well-educated talent pool, abundance of research capabilities in relevant areas from artificial intelligence to regenerative medicine and some of the world's top thinkers in the space, one thing we *don't* have is an adequate amount of wet lab space. The latest CBRE Toronto Lab Market report puts current demand at 1.7 million square feet - we have nowhere near this amount of space. If companies can’t find space here, they will leave for a jurisdiction that offers it. There is progress being made. Last year I spoke at the groundbreaking ceremony of Seeker Labs 155,000 sqft Catalyst development, purpose-built for life sciences scheduled to open its doors less than a year from now. SpinUp at UTM, an incubator for early stage companies at University of Toronto (Mississauga), recently welcomed their first cohort. And, just last week I was fortunate to be a part of SPEC Labs' announcement of a 20,000 sqft multi-tenant wet lab facility in Mississauga, opening Q2 2025. Momentum is promising but we cannot afford to take our foot off the gas. This is a pivotal moment for the Toronto Region in the race to be a top global destination for Life Sciences. 𝙇𝙚𝙩'𝙨 𝙠𝙚𝙚𝙥 𝙩𝙝𝙚 𝙥𝙖𝙘𝙚. For more on the latest in and around the Toronto Region, sign up for the Toronto Global newsletter, delivered straight to your inbox every Tuesday. Link in comments.
To view or add a comment, sign in
-
Thank you Stephen Lund ICD.D for highlighting such a critical gap for the Life Sciences industry, and the Toronto Global Team for your advocacy. We need all stakeholders to contribute in developing our region, and ‘Become the next Boston’ as recently discussed at a Toronto Region Board of Trade conference. How can we address the urgent need for wet space? Can we consider re-purposing existing facilities and/or designing modular infrastructure? Should other forms of equity be used to expedite investments? CC: PDA - Parenteral Drug Association, PDA Canada Chapter, Life Sciences Ontario, PSG Pharmaceutical Sciences Group, AtkinsRéalis, Arthur Kesisyan
The Life Science industry is poised for massive global growth, which *𝙘𝙤𝙪𝙡𝙙* benefit the Toronto region by attracting more foreign-owned companies and improving the retention of home-grown companies looking to scale. While we have many of the required resources to make this a world-class destination for the world's leading life sciences businesses: an incredibly well-educated talent pool, abundance of research capabilities in relevant areas from artificial intelligence to regenerative medicine and some of the world's top thinkers in the space, one thing we *don't* have is an adequate amount of wet lab space. The latest CBRE Toronto Lab Market report puts current demand at 1.7 million square feet - we have nowhere near this amount of space. If companies can’t find space here, they will leave for a jurisdiction that offers it. There is progress being made. Last year I spoke at the groundbreaking ceremony of Seeker Labs 155,000 sqft Catalyst development, purpose-built for life sciences scheduled to open its doors less than a year from now. SpinUp at UTM, an incubator for early stage companies at University of Toronto (Mississauga), recently welcomed their first cohort. And, just last week I was fortunate to be a part of SPEC Labs' announcement of a 20,000 sqft multi-tenant wet lab facility in Mississauga, opening Q2 2025. Momentum is promising but we cannot afford to take our foot off the gas. This is a pivotal moment for the Toronto Region in the race to be a top global destination for Life Sciences. 𝙇𝙚𝙩'𝙨 𝙠𝙚𝙚𝙥 𝙩𝙝𝙚 𝙥𝙖𝙘𝙚. For more on the latest in and around the Toronto Region, sign up for the Toronto Global newsletter, delivered straight to your inbox every Tuesday. Link in comments.
To view or add a comment, sign in
-
🌱 Navigating the Down Market: Strategies for Life Science and Impact Success 🌍 In today's challenging economic landscape, life science and impact organizations face the task of thriving amidst a down market. While downturns can be daunting, they also present opportunities for growth and innovation. How can Life Science Organizations make a positive difference and achieve success during challenging times? #LifeScience #ImpactSuccess #DownMarketStrategies #Collaboration #Innovation #ValueCreation #CustomerCentricity #Adaptability #Resilience
Navigating a down market for life sciences innovators | Grant Thornton
grantthornton.com
To view or add a comment, sign in
-
Our latest research looks at the fundamental building blocks of major life sciences clusters in the U.S. and assesses the landscape of four industry focus areas: medtech, biomanufacturing, AI and talent. Take a closer look ⬇️ ▪️ Life sciences clusters are innovating and evolving across the nation, propelled by synergistic partnerships among academic institutions, research organizations, governmental bodies, and industry leaders. These ecosystems, which require decades to fully mature, are increasingly focused on expanding their capacity to foster groundbreaking scientific advancements. ▪️ Our comprehensive cluster analysis aims not to pinpoint an ideal location for life sciences stakeholders, but rather to provide a holistic view of the industry's most robust environments. Our model evaluates these ecosystems through three critical lenses: access to skilled talent, funding that catalyzes commercialization, and real estate infrastructure that supports sustained growth. By incorporating both aggregate measures and metrics that capture growth, density, and momentum, we can identify not only current powerhouses, but also emerging markets poised for significant expansion. ▪️ Boston retains its position as the preeminent life sciences cluster, despite recent challenges in its real estate sector. Its world-class ecosystem continues to set the standard for excellence. The San Francisco Bay Area and San Diego maintain their second and third-place rankings, respectively, with both markets attracting more venture capital to the sector than in pre-pandemic times. San Diego, in particular, is on track for its second-best year in terms of venture funding. ▪️ While the top 10 clusters feature many familiar names, this year's analysis introduces a notable change by considering Los Angeles and Orange County as a unified market, securing the sixth position overall. Los Angeles maintains an unparalleled lab supply-to-demand ratio, while Orange County leads the nation as the premier medtech hub. Explore the full 2024 Life Sciences Real Estate Perspective and Cluster Analysis >> https://lnkd.in/gMxspawW
To view or add a comment, sign in
-
It’s no secret that 𝐏𝐡𝐢𝐥𝐚𝐝𝐞𝐥𝐩𝐡𝐢𝐚 is a powerhouse in life sciences... But as we highlighted in a previous article, just a short drive away, 𝐋𝐞𝐡𝐢𝐠𝐡 𝐕𝐚𝐥𝐥𝐞𝐲 is emerging as a major player in the industry too. (https://lnkd.in/epgrnn9K) With its unique blend of resources, skilled talent, and supportive business environment, the region is sparking exciting growth in 𝐛𝐢𝐨𝐦𝐚𝐧𝐮𝐟𝐚𝐜𝐭𝐮𝐫𝐢𝐧𝐠, 𝐦𝐞𝐝𝐭𝐞𝐜𝐡, and 𝐩𝐡𝐚𝐫𝐦𝐚. 🌱 Here’s why 𝐋𝐞𝐡𝐢𝐠𝐡 𝐕𝐚𝐥𝐥𝐞𝐲’𝐬 𝐠𝐫𝐨𝐰𝐭𝐡 is great news for the Philadelphia life sciences community and beyond: ➜ 𝐒𝐭𝐫𝐚𝐭𝐞𝐠𝐢𝐜 𝐋𝐨𝐜𝐚𝐭𝐢𝐨𝐧 📍 ☑ Positioned between 𝐏𝐡𝐢𝐥𝐚𝐝𝐞𝐥𝐩𝐡𝐢𝐚, 𝐍𝐘𝐂, and 𝐖𝐚𝐬𝐡𝐢𝐧𝐠𝐭𝐨𝐧 𝐃.𝐂., Lehigh Valley offers life sciences companies ideal access to key markets without the high costs of major cities. ➜ 𝐓𝐚𝐥𝐞𝐧𝐭 & 𝐖𝐨𝐫𝐤𝐟𝐨𝐫𝐜𝐞 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭 🧑🔬 ☑ Institutions like Lehigh University and Pennsylvania State University-Penn State Lehigh Valley are fostering the next generation of skilled life sciences professionals, addressing the high demand for 𝐛𝐢𝐨𝐭𝐞𝐜𝐡 and 𝐩𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥 talent. ➜ 𝐁𝐮𝐬𝐢𝐧𝐞𝐬𝐬-𝐅𝐫𝐢𝐞𝐧𝐝𝐥𝐲 𝐄𝐧𝐯𝐢𝐫𝐨𝐧𝐦𝐞𝐧𝐭 💼 ☑ Lehigh Valley’s favorable policies and infrastructure investments create fertile ground for startups, established companies, and R&D centers alike. ➜ 𝐂𝐨𝐥𝐥𝐚𝐛𝐨𝐫𝐚𝐭𝐢𝐯𝐞 𝐄𝐜𝐨𝐬𝐲𝐬𝐭𝐞𝐦 🤝 ☑ Close proximity to Philadelphia allows for cross-regional partnerships in 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡, 𝐝𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭, and 𝐜𝐨𝐦𝐩𝐥𝐢𝐚𝐧𝐜𝐞, connecting Philly’s established life sciences network with Lehigh Valley’s emerging infrastructure. ➜ 𝐆𝐫𝐨𝐰𝐢𝐧𝐠 𝐁𝐢𝐨𝐭𝐞𝐜𝐡 & 𝐌𝐞𝐝𝐭𝐞𝐜𝐡 𝐏𝐫𝐞𝐬𝐞𝐧𝐜𝐞 🧬 ☑ With a surge in 𝐛𝐢𝐨𝐭𝐞𝐜𝐡 and 𝐦𝐞𝐝𝐭𝐞𝐜𝐡 companies, from startups to large manufacturers, the region is expanding its capabilities in 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡, 𝐝𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭, and 𝐩𝐫𝐨𝐝𝐮𝐜𝐭𝐢𝐨𝐧. As our previous article highlights, Lehigh Valley’s growth complements Philadelphia’s established life sciences scene, together building a powerful ecosystem that drives innovation, quality, and compliance across the industry. 🚀 𝐖𝐡𝐚𝐭 𝐨𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐢𝐞𝐬 𝐝𝐨 𝐲𝐨𝐮 𝐬𝐞𝐞 𝐢𝐧 𝐋𝐞𝐡𝐢𝐠𝐡 𝐕𝐚𝐥𝐥𝐞𝐲’𝐬 𝐥𝐢𝐟𝐞 𝐬𝐜𝐢𝐞𝐧𝐜𝐞𝐬 𝐛𝐨𝐨𝐦? Let’s hear your thoughts! 👇 #LehighValley #LifeSciences #Philadelphia #Biotech #Innovation #Healthcare #Compliance #Pharma #Ellab #Collaboration (Based on insights from “𝘓𝘦𝘩𝘪𝘨𝘩 𝘝𝘢𝘭𝘭𝘦𝘺: 𝘈 𝘉𝘰𝘰𝘮𝘪𝘯𝘨 𝘓𝘪𝘧𝘦 𝘚𝘤𝘪𝘦𝘯𝘤𝘦𝘴 𝘌𝘤𝘰𝘴𝘺𝘴𝘵𝘦𝘮 𝘙𝘪𝘨𝘩𝘵 𝘕𝘦𝘹𝘵 𝘋𝘰𝘰𝘳” by BioBuzz) 𝐑𝐞𝐚𝐝 𝐌𝐨𝐫𝐞 here: https://lnkd.in/epgrnn9K
To view or add a comment, sign in